T2 BIOSYSTEMS INC's ticker is TTOO and the CUSIP is 89853L104. A total of 97 filers reported holding T2 BIOSYSTEMS INC in Q4 2018. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $9,000 | -71.0% | 59,150 | 0.0% | 0.00% | – |
| Q1 2022 | $31,000 | 0.0% | 59,150 | -1.3% | 0.00% | – |
| Q4 2021 | $31,000 | -52.3% | 59,900 | -13.7% | 0.00% | – |
| Q3 2021 | $65,000 | -22.6% | 69,400 | -1.8% | 0.00% | – |
| Q2 2021 | $84,000 | -23.6% | 70,650 | +4.0% | 0.00% | – |
| Q1 2021 | $110,000 | +22.2% | 67,950 | -8.1% | 0.00% | – |
| Q4 2020 | $90,000 | -11.8% | 73,950 | -1.3% | 0.00% | – |
| Q3 2020 | $102,000 | +64.5% | 74,950 | +54.4% | 0.00% | – |
| Q2 2020 | $62,000 | +181.8% | 48,550 | +37.9% | 0.00% | – |
| Q1 2020 | $22,000 | -12.0% | 35,200 | +245.1% | 0.00% | – |
| Q3 2019 | $25,000 | -68.4% | 10,200 | -78.6% | 0.00% | – |
| Q2 2019 | $79,000 | -31.3% | 47,775 | +9.9% | 0.00% | -100.0% |
| Q1 2019 | $115,000 | -12.2% | 43,475 | +0.6% | 0.00% | 0.0% |
| Q4 2018 | $131,000 | -39.1% | 43,195 | +45.5% | 0.00% | -50.0% |
| Q3 2018 | $215,000 | – | 29,685 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 1,841,924 | $13,722,000 | 6.87% |
| Senvest Management, LLC | 2,769,931 | $20,636,000 | 1.56% |
| Bell Rock Capital LLC | 291,835 | $2,176,000 | 1.07% |
| ARDSLEY ADVISORY PARTNERS LP | 935,000 | $6,966,000 | 0.94% |
| TIGER MANAGEMENT L.L.C. | 967,585 | $7,209,000 | 0.72% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 677,433 | $5,047,000 | 0.59% |
| THOMPSON DAVIS & CO., INC. | 33,153 | $247,000 | 0.54% |
| PERKINS CAPITAL MANAGEMENT INC | 69,700 | $519,000 | 0.31% |
| Schonfeld Strategic Advisors LLC | 322,700 | $2,404,000 | 0.11% |
| Phoenix Investment Adviser LLC | 8,000 | $60,000 | 0.08% |